This review, recently published in our partner journal Future Microbiology, discusses the pharmacology of oteseconazole and summarizes clinical studies investigating…
New encapsulating technology for whole-cell vaccines stimulates enhanced immunogenicity against Escherichia coli in a mouse model, shaping the future of urinary tract infection (UTI) vaccines. Recurrent…
Plant natural products represent a largely untapped resource for discovering bioactive compounds to fill the antimicrobial drug development pipeline. With…
A historic moment: WHO recommends deployment of a malaria vaccine finally developed after a 100-year endeavour. The WHO have advised that the RTS,S/AS01 vaccine, also known as Mosquirix, developed by GlaxoSmithKline (London, England) over the last 30 years in…
Researchers discover bacteriophage ‘Muddy’ and antibiotic rifabutin as a new dynamic duo combination therapy against antibiotic-resistant Mycobacterium abscessus infection in a cystic fibrosis zebrafish model. A group of researchers…
Phase III trials for the VLA1553 vaccine against chikungunya virus indicated promising results by inducing protective CHIKV neutralizing antibody titers…
Researchers discover the role of stem cells in gut lymphoid tissue regeneration and enhanced immunity against SIV in non-human primate…
Candida auris is a fungus often found in the hospital environment that can cause life-threatening infections, and has attracted increased…
Novel and emerging infectious diseases can be a serious threat to human health and the global economy. To mitigate these…
Researchers have discovered certain bacteria that reside in the human intestine secrete compounds that inhibit SARS-CoV-2. Research from Yonsei…
